Home > News

News

Ranbaxy Laboratories Ltd v Warner-Lambert Co [2007] IEHC 25610 July 2007A team from chambers (James Mellor QC, Michael Tappin and Jessie Bowhill) recently represented Ranbaxy at the trial in the High Court of Ireland of its claim for a declaration of non-infringement of one of Warner-Lambert’s patents. The litigation concerns the cholesterol-lowering agent atorvastatin (sold by Warner-Lambert as Lipitor ®). Previously Michael Tappin had represented […]
Source Code Delivery Up1 July 2007In 2007 James St.Ville completed three actions to do with source code delivery up. The first, Duffy v. TIARC, related to the source code for web pages. The second, EGroup v. Baker, related to the source code for search engine software. The third, Meridian International v. IP Enterprises, began with a successful application for interim […]
Intel -v- CPM15 May 2007In June 2008, Advocate-General Sharpston gave her preliminary ruling in the ECJ in Intel v. CPM. The case concerns the extent to which well known marks can be protected against dilution. James Mellor QC acted for Intel.
Intel Corporation Inc. v CPM UK Ltd C-252/0715 May 2007James Mellor QC appeared on behalf of Intel in front of the European Court of Justice. The ECJ handed down its judgment in November 2008 after Advocate General Sharpston gave her opinion in June of the same year. The ECJ addressed the issue of what is needed in order to establish the ‘link’ that is […]
Generics (UK) Ltd and Arrow Generics Limited -v- H. Lundbeck A-S [2007] EWHC 1040 (Pat)4 May 2007A pharmaceutical patent action in March 2007, concerning the single enantiomer of the successful anti-depressant citalopram (Cipramil®), namely escitalopram (Cipralex®). Attacks were brought on the basis of anticipation, obviousness and (Biogen) insufficiency. A broad range of defences were run, including commercial success, an alleged after-discovered benefit and an argument that the current UK approach to […]